Maya MacDonaldLiu Huan, the baritone voice of China's popular music era who performed alongside Sarah Brightman at the 2008 Beijing Olympics opening ceremony, died on the morning of September 25, 2026, at a Shanghai hospital. He was 63. His employer, the University of International Business and Economics, confirmed his passing at 9:52 a.m. but did not name an official cause. What colleagues, fans, and fellow musicians had witnessed over the previous decade told a quieter story: Liu had been slowly losing ground to avascular necrosis, a progressive bone condition that forced him onto crutches and withdrew him from public life long before his death.
For Canada's 1.7 million Chinese-Canadians — and millions more worldwide who grew up with his voice — his passing marks the end of an era. It also raises a question that bone health specialists across the country hear far too often: by the time a patient finally seeks help, how much irreversible damage has already been done?
The Man Behind the Music
Born in Tianjin in August 1963, Liu Huan spent four decades turning Western pop sensibilities into something distinctly Chinese. He studied at the University of International Business and Economics, where he later taught French and music, and became one of the first mainland artists to embrace a stadium-scale sound. His catalogue spans bluesy ballads, sweeping orchestral themes, and television soundtracks that became the sonic wallpaper of an entire generation's childhood.
His most watched performance came at the Beijing Olympics, where he duetted with British soprano Sarah Brightman on "You and Me" before a live audience of 91,000 at the Bird's Nest stadium — a broadcast estimated to have reached four billion viewers worldwide. Later, as a vocal mentor on The Voice of China, he introduced a younger audience to the discipline of classical vocal training.
By the early 2010s, however, Liu's public appearances grew increasingly rare. Photographs from the few events he did attend showed him leaning heavily on crutches. Friends and colleagues described a condition that had been quietly worsening for years: avascular necrosis of the hip, also called osteonecrosis, had been diagnosed roughly a decade before his death and had progressed to the point where sustained mobility was no longer possible.
What Avascular Necrosis Actually Does to the Body
Avascular necrosis (AVN) occurs when the blood supply to a section of bone is interrupted, starving bone cells of the oxygen and nutrients they need to survive. Unlike muscle tissue, bone has limited capacity to compensate through alternative circulation, which means damage accumulates over time rather than healing. The hip joint is the most commonly affected site, though the condition can also attack the shoulder, knee, and wrist.
In the early stages — often called stage I or II — there are frequently no symptoms at all. Patients may notice nothing, or attribute a faint ache in the groin or outer thigh to overexertion. It is precisely this quiet onset that makes diagnosis routinely late. As the condition progresses to stage III and beyond, the femoral head — the ball-shaped top of the thigh bone — begins to lose its structural integrity and eventually collapses inward.
Causes are varied. Trauma, particularly fractures close to the hip joint, can cut off circulation directly. Prolonged corticosteroid use is one of the most common non-traumatic triggers, accounting for approximately 35% of all non-traumatic AVN cases according to clinical literature. Heavy alcohol consumption, blood-clotting disorders, lupus, and certain chemotherapy regimens also appear consistently in the risk-factor data.
The global market for AVN treatment reached $0.89 billion in 2025 and is forecast to grow to $0.97 billion in 2026, a compound annual growth rate of 9.5% — a figure that reflects not only rising diagnosis rates but also expanding demand for joint-preserving interventions. This is not a rare disease. It is an underdiagnosed one.
Why It Hides in Plain Sight for Years
The trajectory of Liu Huan's illness mirrors what orthopedic surgeons in Canada encounter regularly. A patient notices intermittent hip or groin discomfort. The pain comes and goes; it improves with rest. A general practitioner orders a standard X-ray, which often returns unremarkable results in early-stage AVN because plain radiography cannot reliably detect the condition until bone architecture has already been compromised. Months pass. Reassurance is given. The condition continues to advance.
By the time an MRI is ordered and AVN is confirmed at stage III or IV, the femoral head has typically begun to collapse. At that stage, joint-preserving treatment options narrow dramatically. Surgical decompression — drilling small channels into the affected bone to relieve pressure and stimulate new blood-vessel formation — shows success rates of 60 to 80% when applied at stage I or II. Once structural collapse begins, that figure drops below 20%, according to data cited in Canadian diagnostic guidance from the Canadian Drug and Health Technology Agency (CDA-AMC). At advanced stages, total hip replacement becomes the most realistic outcome.
Early imaging — specifically MRI, not X-ray — is the diagnostic standard for suspected AVN. A two-to-three month lag between symptom onset and MRI referral can be the difference between a same-day outpatient procedure and a five-day hospital admission.
What This Means for You: A Concrete Case
Consider this scenario, which reflects a pattern orthopedic specialists across Canada recognize:
A 48-year-old accountant in Vancouver — no history of major trauma, no heavy alcohol use, but a two-year course of prednisone for a rheumatoid condition that ended three years ago — begins noticing a dull ache in his right groin when climbing stairs. The discomfort started about seven months before he mentions it to his family doctor. He assumed it was a muscle strain. His physician orders a pelvic X-ray; the radiology report comes back normal. He is prescribed anti-inflammatories for six weeks. The pain does not fully resolve.
Had he been referred for an MRI at that six-week mark — the threshold widely referenced in orthopedic clinical literature for unexplained joint pain that fails to respond to conservative management — his prior corticosteroid use would have immediately placed him in a high-risk category warranting urgent imaging. An MRI would likely have caught stage I or II disease.
Instead, four more months pass. When pain escalates to 6/10 even at rest, an MRI is finally ordered. The report shows early-to-mid stage III AVN with beginning of femoral head flattening. His orthopedic surgeon now presents two options: a core decompression procedure (covered under British Columbia's provincial health plan, outpatient surgery, 1–2 hours, return to light work in 4–6 weeks) with a 40–55% chance of halting further progression at this stage, or a trajectory toward total hip replacement within two to four years.
If you have experienced unexplained hip, groin, or thigh discomfort lasting more than six weeks that does not fully resolve with rest and over-the-counter anti-inflammatories — and especially if you have a history of corticosteroid use, alcohol-use disorder, blood-clotting conditions, or autoimmune disease — then the appropriate step is an MRI referral, not reassurance from a normal X-ray. An X-ray that shows nothing does not rule out AVN in its early and still-treatable stages.
That six-week threshold matters. In the window between six weeks and four months, most patients with early-stage AVN still have access to joint-preserving intervention. Beyond the four-month mark without imaging, the probability of catching the disease before structural collapse begins to decline sharply.
When a Specialist Consultation Can Change Everything
The path from "this is probably nothing" to "you need a hip replacement" can unfold in under 18 months. Liu Huan's case, while unusually prolonged, reflects a compressed version of what thousands of Canadians experience quietly each year — often attributing joint pain to aging, sedentary work, or minor injury rather than a treatable underlying condition.
An orthopedic surgeon, a rheumatologist, or a sports-medicine physician with experience in bone pathology can order an MRI, interpret the staging, and present a treatment map before collapse occurs. For patients with known risk factors — corticosteroid history, alcohol dependency, or a recent hip fracture — many specialists recommend baseline MRI screening proactively, even before pain appears.
Liu Huan's voice filled stadiums and living rooms for four decades. He had a decade of warning signs. The question for Canadians living with unexplained joint discomfort is whether they will act on theirs sooner than he was able to.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. If you are experiencing joint pain or have risk factors associated with avascular necrosis, consult a qualified healthcare professional.
